Diabetes Online-Kongress 2021
zur Liste
Dr. Elke Heitmann
Lilly Deutschland GmbH Germany
  • Vortrag The Real-World Observational Prospective Study of Health Outcomes with Dulaglutide & Liraglutide in Type 2 Diabetes Patients (TROPHIES): 6-month analysis results Speaker
    Datum: 14.05.2021 , Zeit: 08:37 | Thema: Posterkurzvortrag
    Details
  • Vortrag Clinical characteristics, treatment patterns and persistence in patients with T2D initiating a Glucagon-like-peptide 1 receptor agonists (GLP-1 RA): a retrospective analysis of the Diabetes Prospective Follow-Up (DPV) registry Autor
    Datum: 14.05.2021 , Zeit: 08:44 | Thema: Posterkurzvortrag
    Details
  • Vortrag Efficacy of investigational dulaglutide doses overall and by baseline HbA1c and Body Mass Index (BMI): exploratory subgroup analyses of the AWARD-11 trial Speaker
    Datum: 14.05.2021 , Zeit: 08:51 | Thema: Posterkurzvortrag
    Details
  • Vortrag The Real-World Observational Prospective Study of Health Outcomes with Dulaglutide and Liraglutide in Type 2 Diabetes Patients (TROPHIES): Design and Baseline Characteristics Autor
    Datum: 14.05.2021 , Zeit: 09:05 | Thema: Posterkurzvortrag
    Details

zur online Kongressplattform